Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 2/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25500275 | 0.93 | HIF1A (0.46) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL19765254 | 0.92 | MEN1 (0.43) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL5084116 | 0.91 | THRB (0.52) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL12196922 | 0.90 | HTT (0.50) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL22522046 | 0.90 | HTT (0.45) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL11967037 | 0.89 | HTT (0.53) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL195095 | 0.89 | HTT (0.53) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL14173204 | 0.89 | HTT (0.53) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL22754450 | 0.88 | HTT (0.46) | MEN1KMT2ATHRBKDM4EALDH1A1 | |
| SCHEMBL14588120 | 0.87 | HTT (0.49) | MEN1KMT2ATHRBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57133107-A | — | — | None | — | — | JP | disclosed |
| US-8927182-B2 | Photosensitive resist composition for color filters for use in electronic paper display devices | BASF SE (DE) | 2015-01-06 | — | — | US | disclosed |
| US-8927182-B2 | Photosensitive resist composition for color filters for use in electronic paper display devices | BASF SE (DE) | 2015-01-06 | — | — | US | disclosed |
| US-20100164911-A1 | PHOTOSENSITIVE RESIST COMPOSITION FOR COLOR FILTERS FOR USE IN ELECTRONIC PAPER DISPLAY DEVICES | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100164911-A1 | PHOTOSENSITIVE RESIST COMPOSITION FOR COLOR FILTERS FOR USE IN ELECTRONIC PAPER DISPLAY DEVICES | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| WO-2007113107-A1 | PHOTOSENSITIVE RESIST COMPOSITION FOR COLOR FILTERS FOR USE IN ELECTRONIC PAPER DISPLAY DEVICES | CIBA HOLDING INC. (CH) | 2007-10-11 | — | — | WO | disclosed |
| JP-S57133107-A | THERMOSETTING LIQUID RESIN COMPOSITION | OSAKA SODA CO LTD | 1982-08-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100164911-A1 | PHOTOSENSITIVE RESIST COMPOSITION FOR COLOR FILTERS FOR USE IN ELECTRONIC PAPER DISPLAY DEVICES | EYA2, PTPN4, PTPN5 | MEN1 1899/4885KMT2A 1194/4885THRB 4781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.